MoneyWorks4Me

Lupin informs about company updates

20 Dec 2019 Evaluate

Lupin has informed about the Press Note as regards Lupin facilitating a new initiative 'The Best of ACG ' in association with American College of Gastroenterology. This may be considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2104.60 -30.40 (-1.42%)
04-Sep-2026 15:03 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1901.60
Dr. Reddys Labs. 1156.05
Cipla 1378.00
Lupin 2104.60
Zydus Lifesciences 1125.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: